Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Rayner Launches First Blue Light Filtering IOL
Rayner announced the launch of the RayOne Hydrophobic BLF, Rayner’s first blue light filtering intraocular lens. RayOne Hydrophobic BLF, made of Rayner’s patented ultra glistening-free hydrophobic material, expands Rayner’s RayOne lens from seven to eight variants. The lens provides surgeons…
Climate Change Linked to Eye Health Issues
A groundbreaking study from the University of Colorado Anschutz Medical Campus has identified a significant association between air pollution caused by climate change and an increase in ocular surface conditions. Clinical visits for these conditions more than doubled during periods…
Hubble Contacts Under Fire: Lawsuit Filed for Vision Loss
Stephanie Guarisco, a woman from New Mexico, has filed a lawsuit against Hubble Contacts, alleging that the company’s contact lenses resulted in the “total loss” of her right eye. According to the lawsuit, Guarisco underwent a complete removal of her…
COVID-19 Tied to Rise in Acute Macular Neuroretinopathy
A recent Chinese study highlights a rise in cases of acute macular neuroretinopathy (AMN) and related retinal conditions coinciding with the COVID-19 outbreak. Dr. Xiaojia Song, MD, from Beijing Tongren Eye Center and Qilu Hospital of Shandong University, led the…
Stem Cell Breakthrough Restores Vision in LSCD Patients
In a groundbreaking achievement, researchers from Osaka University in Japan have successfully conducted the first human trial using induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency (LSCD). This innovative approach marks a significant advancement in vision restoration…
Bimekizumab Reduces Uveitis Incidence in axSpA Patients
The study led by Matthew A. Brown, Genomics England, London, United Kingdom, and Martin Rudwaleit, Klinikum Bielefeld, University of Bielefeld, Bielefeld, Germany. Patients with axial spondyloarthritis (axSpA) treated with bimekizumab exhibited a markedly lower incidence of uveitis compared to those receiving…
Nerve Regrowth Breakthrough for Blindness
Researchers at the University of Connecticut have uncovered promising findings that may pave the way for treating a common cause of blindness. The study, published in the September issue of Experimental Neurology, demonstrates how injured optic nerves in mice can…
U.S. Glaucoma Prevalence and Risk Factors Study
A new study titled “Prevalence of Glaucoma Among US Adults in 2022”, published in JAMA Ophthalmology, has revealed updated statistics on the prevalence of glaucoma in the United States. The research shows that approximately 4.22 million U.S. adults (1.62% of…
Rethinking Dry Eye Diagnosis in Resistant Patients
Many conditions can mimic dry eye disease (DED), leading to misdiagnoses and ineffective treatments, warned Vatinee Y. Bunya, MD, MSCE, during a presentation at Cornea Subspecialty Day at the American Academy of Ophthalmology meeting. Dr. Bunya emphasized the need for…
Ocular Side Effects Linked to Ovarian Cancer Drug
A recent study presented at the American Academy of Ophthalmology (AAO) meeting in Chicago has identified significant ocular side effects associated with mirvetuximab soravtansine (Elahere), a drug approved for ovarian cancer treatment. The research, conducted by Stanford University, highlights the…